Debt-to-equity of Viking Therapeutics, Inc. from 30 Sep 2015 to 31 Dec 2025

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Viking Therapeutics, Inc. quarterly Debt-to-equity in % history and change rate from 30 Sep 2015 to 31 Dec 2025.
  • Viking Therapeutics, Inc. Debt-to-equity for the quarter ending 31 Dec 2025 was 5.2%, a 66% increase year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Change (%)

Viking Therapeutics, Inc. Quarterly Debt-to-equity (%)

Period Value YoY Chg Change % Date
Q4 2025 5.2% +2.1% +66% 31 Dec 2025
Q3 2025 3.3% -0.1% -2.9% 30 Sep 2025
Q2 2025 3.1% -0.54% -15% 30 Jun 2025
Q1 2025 2.8% -1.2% -31% 31 Mar 2025
Q4 2024 3.1% -2.2% -41% 31 Dec 2024
Q3 2024 3.4% -3.3% -49% 30 Sep 2024
Q2 2024 3.6% -4.9% -57% 30 Jun 2024
Q1 2024 4.1% -8% -66% 31 Mar 2024
Q4 2023 5.3% -5.2% -49% 31 Dec 2023
Q3 2023 6.7% -0.92% -12% 30 Sep 2023
Q2 2023 8.6% +2.1% +33% 30 Jun 2023
Q1 2023 12% +6.5% +116% 31 Mar 2023
Q4 2022 10% +5.3% +101% 31 Dec 2022
Q3 2022 7.6% +2.2% +42% 30 Sep 2022
Q2 2022 6.4% +1.5% +30% 30 Jun 2022
Q1 2022 5.6% +1.1% +26% 31 Mar 2022
Q4 2021 5.2% +1.3% +34% 31 Dec 2021
Q3 2021 5.4% +2.1% +62% 30 Sep 2021
Q2 2021 5% +2.1% +70% 30 Jun 2021
Q1 2021 4.4% +1.9% +72% 31 Mar 2021
Q4 2020 3.9% +1.7% +75% 31 Dec 2020
Q3 2020 3.3% +1.3% +68% 30 Sep 2020
Q2 2020 2.9% +1.2% +65% 30 Jun 2020
Q1 2020 2.6% +0.74% +41% 31 Mar 2020
Q4 2019 2.2% -0.21% -8.5% 31 Dec 2019
Q3 2019 2% -2.6% -57% 30 Sep 2019
Q2 2019 1.8% -11% -86% 30 Jun 2019
Q1 2019 1.8% -32% -95% 31 Mar 2019
Q4 2018 2.4% -110% -98% 31 Dec 2018
Q3 2018 4.5% -124% -96% 30 Sep 2018
Q2 2018 13% -74% -85% 30 Jun 2018
Q1 2018 34% -33% -49% 31 Mar 2018
Q4 2017 113% +44% +64% 31 Dec 2017
Q3 2017 129% +61% +89% 30 Sep 2017
Q2 2017 86% +24% +39% 30 Jun 2017
Q1 2017 67% +13% +25% 31 Mar 2017
Q4 2016 69% -346% -83% 31 Dec 2016
Q3 2016 68% +412% 30 Sep 2016
Q2 2016 62% 30 Jun 2016
Q1 2016 54% 31 Mar 2016
Q4 2015 415% 31 Dec 2015
Q3 2015 -344% 30 Sep 2015
* An asterisk sign (*) next to the value indicates that the value is likely invalid.